DeepMed Research

Arkansas State University

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1909-01-01

Employees: 251

Market Cap: -

Website: http://www.astate.edu

Clinical Trials

Mitochondrial Dysfunction in Autism Spectrum Disorder

Active, not recruiting

Conditions: Developmental Delay
Autism Spectrum Disorder
Mitochondrial Disease
Autism

First Posted Date: 2013-12-04

Last Posted Date: 2025-02-05

Lead Sponsor: University of Arkansas

Target Recruit Count: 297

Registration Number: NCT02000284

Locations: 🇺🇸
Arkansas Children's Hospital Research Institute, Little Rock, Arkansas, United States

Mitochondrial Dysfunction in Phelan-McDermid Syndrome

Completed

Conditions: Phelan-McDermid Syndrome

First Posted Date: 2013-12-03

Last Posted Date: 2021-08-05

Lead Sponsor: University of Arkansas

Target Recruit Count: 51

Registration Number: NCT02000167

Locations: 🇺🇸
Arkansas Children's Hospital Research Institute, Little Rock, Arkansas, United States

Efficacy of Fluorescein Visualization of the Uterus in Detecting Endometrial Cancer Invasion

Early Phase 1

Completed

Conditions: Endometrial Cancer

Interventions: Drug: Fluorescein

First Posted Date: 2013-11-08

Last Posted Date: 2022-02-24

Lead Sponsor: University of Arkansas

Target Recruit Count: 100

Registration Number: NCT01979003

Locations: 🇺🇸
University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States

Evaluation of a Microendoscopic Imaging System in Examination of Resected Tissues

Terminated

Conditions: Known or Suspected Dysplasia or Cancer

First Posted Date: 2013-10-24

Last Posted Date: 2015-07-10

Lead Sponsor: University of Arkansas

Target Recruit Count: 13

Registration Number: NCT01968863

Locations: 🇺🇸
University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States

Is a Smartphone Application Effective as an Oral Medication Adherence Aid

Early Phase 1

Terminated

Conditions: Diabetes
Dyslipidemia
Hypertension

Interventions: Other: Medication Adherence Smartphone App

First Posted Date: 2013-10-24

Last Posted Date: 2017-11-20

Lead Sponsor: University of Arkansas

Target Recruit Count: 68

Registration Number: NCT01968876

Locations: 🇺🇸
Remedy Drug, Little Rock, Arkansas, United States
🇺🇸
Internal Medicine Clinic West; University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
🇺🇸
Internal Medicine Clinic North; University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States

Understanding GRID Radiation Therapy Effects on Human Tumor Oxygenation and Interstitial Pressure to Increase Translation of Solid Tumor Therapy

Early Phase 1

Withdrawn

Conditions: Squamous Cell Carcinoma of the Head and Neck

Interventions: Drug: 18F-MISO

First Posted Date: 2013-10-23

Last Posted Date: 2021-08-19

Lead Sponsor: University of Arkansas

Registration Number: NCT01967927

Locations: 🇺🇸
University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States

Improving Anticoagulant Therapy Through Warfarin Metabolite Profiling

Completed

Conditions: Stable Target INR

First Posted Date: 2013-10-17

Last Posted Date: 2016-10-07

Lead Sponsor: University of Arkansas

Target Recruit Count: 60

Registration Number: NCT01964794

Locations: 🇺🇸
Central Arkansas Veterans Healthcare System, Little Rock, Arkansas, United States
🇺🇸
University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States

Improving Buprenorphine Detoxification Outcomes With Isradipine

Phase 1

Completed

Conditions: Opioid Dependence

Interventions: Drug: Placebo
Drug: Isradipine

First Posted Date: 2013-07-10

Last Posted Date: 2017-06-05

Lead Sponsor: University of Arkansas

Target Recruit Count: 28

Registration Number: NCT01895270

Locations: 🇺🇸
UAMS Psychiatric Research Institute, Little Rock, Arkansas, United States

UARK 2013-05 A Study of Autologous Expanded Natural Killer Cell Therapy for Asymptomatic Multiple Myeloma

Phase 2

Completed

Conditions: Asymptomatic Multiple Myeloma

Interventions: Drug: ENK Cell Infusion

First Posted Date: 2013-06-24

Last Posted Date: 2017-04-17

Lead Sponsor: University of Arkansas

Target Recruit Count: 3

Registration Number: NCT01884688

Locations: 🇺🇸
University of Arkansas for Medical Science, Little Rock, Arkansas, United States

A Randomized Pilot Study to Evaluate the Effects of a Short Course of Metformin Versus No Therapy in the Period Prior to Hysterectomy for Grade 1-2 Adenocarcinoma of the Endometrium in Obese Non-Diabetic Women

Phase 2

Completed

Conditions: Adenocarcinoma of the Endometrium

Interventions: Drug: Metformin

First Posted Date: 2013-06-13

Last Posted Date: 2017-10-25

Lead Sponsor: University of Arkansas

Target Recruit Count: 10

Registration Number: NCT01877564

Locations: 🇺🇸
University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy